Lockerman Financial Group, Inc. Johnson & Johnson Transaction History

Lockerman Financial Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 20, 2023	BUY	$154.35 - $166.11 $11,576 - $12,458	75 Added 2.92%	2,641 $437,000
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $17,823 - $21,270	-118 Reduced 4.4%	2,566 $397,000
Q4 2022 Feb 07, 2023	BUY	$160.2 - $179.79 $9,932 - $11,146	62 Added 2.36%	2,684 $474,000
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $49,528 - $55,112	307 Added 13.26%	2,622 $428,000
Q2 2022 Jul 22, 2022	BUY	$168.19 - $186.01 $8,745 - $9,672	52 Added 2.3%	2,315 $411,000
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $11,702 - $13,289	-74 Reduced 3.17%	2,263 $401,000
Q4 2021 May 10, 2022	BUY	$155.93 - $173.01 $364,408 - $404,324	2,337 New	2,337 $400,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Lockerman Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Lockerman Financial Group, Inc. with notifications on news.